Letrozole and ribociclib and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Letrozole and ribociclib and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: n.a.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Letrozole and ribociclib-Moxifloxacin
- Letrozole and ribociclib-Moxifloxacin (Systemic)
- Letrozole and ribociclib-Moxifloxacin Hydrochloride
- Letrozole and ribociclib-Moxifloxacin Injection
- Letrozole and ribociclib-Moxifloxacin Intravenous
- Letrozole and ribociclib-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Leucovorin
- Moxetumomab pasudotox-tdfk Intravenous-Leucovorin Calcium
- Moxetumomab pasudotox-tdfk Intravenous-Leucovorin injection
- Moxetumomab pasudotox-tdfk Intravenous-Leucovorin Oral, Intravenous, Injection
- Moxetumomab pasudotox-tdfk Intravenous-Leucovorin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Leukeran